NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.
As a result, the Louisville, Ky.-based company can offer its testing services in all 50 states in the US, it said. According to PGXL's website, it provides pharmacogenetic tests for CYP2C19, CYP2D6, Factor V Leiden, Factor II, and others. It also offers molecular oncology testing for the detection of EGFR, HER2/neu (fluorescent in situ hybridization), JAK2, ALK (FISH), and other genes.
PGXL operates as a commercial and research lab and said that in 2001 it was the first laboratory CLIA-certified specifically to offer pharmacogenetic tests.